indrawan james mcalpine
Pfizer
New York, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Editorial Board
Type at least 3 characters
1,064 editors
Shape the future of research in your field
Join the board
Editors
Review Editors
kyle douglas mcintosh
Oak Ridge Institute for Science and Education (ORISE)
Oak Ridge, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
da-li meng
Shenyang Pharmaceutical University
Shenyang, China
Review Editor
Pharmacology of Anti-Cancer Drugs
zhefeng meng
Fudan University
Shanghai, China
Review Editor
Pharmacology of Anti-Cancer Drugs
daniele mengato
University Hospital of Padua
Padua, Italy
Review Editor
Pharmacology of Anti-Cancer Drugs
venkatram mereddy
University of Minnesota Duluth
Duluth, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
angelica merlot
University of New South Wales
Kensington, Australia
Review Editor
Pharmacology of Anti-Cancer Drugs
felipe pantoja mesquita
Federal University of Ceara
Fortaleza, Brazil
Review Editor
Pharmacology of Anti-Cancer Drugs
mohamed fares metwaly
The University of Sydney
Darlington, Australia
Review Editor
Pharmacology of Anti-Cancer Drugs
olivier micheau
Institut National de la Santé et de la Recherche Médicale (INSERM)
Paris, France
Review Editor
Pharmacology of Anti-Cancer Drugs
li min
West China Hospital, Sichuan University
Chengdu, China
Review Editor
Pharmacology of Anti-Cancer Drugs
ganesh prasad mishra
Swami Vivekanand Subharti University
Meerut, India
Review Editor
Pharmacology of Anti-Cancer Drugs
pinaki misra
Mayo Clinic
Rochester, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
roopali mittal
University of Oklahoma Health Sciences Center
Oklahoma City, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
shohei mizuno
Aichi Medical University
Nagakute, Japan
Review Editor
Pharmacology of Anti-Cancer Drugs
pingli mo
School of Life Sciences, Xiamen University
Xiamen, China
Review Editor
Pharmacology of Anti-Cancer Drugs